Drugs / ALBIS
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02175186 | Jan 2015 → Dec 2018 | gastritis, peptic ulcer disease | Young-Hak Kim, MD, PhD | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ALBIS | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02175186 ↗ |
| Route | Oral | “Albis Tab 2 tab twice a day 12weeks” NCT02175186 ↗ |